Some Pa. cannabis companies use misleading, inaccurate or dangerous statements to promote marijuana for addiction treatment

published on February 21, 2022 by Ed Mahon in Centre Daily Times

HARRISBURG — Some Pennsylvania cannabis companies are using incomplete or misleading claims to promote marijuana as a treatment for opioid addiction, potentially putting patients’ lives at greater risk, a Spotlight PA investigation has found.

In a first-of-its-kind review, Spotlight PA examined more than 60 websites offering services in Pennsylvania and consulted numerous health policy experts about the validity of the claims. In some instances where medical research was cited on a website or by a company official, the news organization directly contacted study authors.

The investigation found a wide range of misleading tactics: cherry-picking and misrepresenting parts of studies, making broad claims without citing any specific research, and providing incomplete information about what it takes to qualify for the state’s medical marijuana program.

About half the websites promoted cannabis dispensaries, while the other half were for physicians or companies that help certify patients…

View the full article